| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |